Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 2/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | PAM | P19021 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27972005 | 0.86 | CES1 (0.57) | CES1CES2AKR1B1TSHRCYP2C19 | |
| SCHEMBL1195864 | 0.82 | CES1 (0.57) | CES1CES2AKR1B1TSHRCYP2C19 | |
| SCHEMBL7558091 | 0.82 | CES1 (0.61) | CES1CES2AKR1B1TSHRALDH1A1 | |
| SCHEMBL30196221 | 0.80 | CES1 (0.59) | CES1CES2AKR1B1TSHRCYP2C19 | |
| SCHEMBL13545191 | 0.80 | OPRM1 (0.51) | CES1CES2TSHRCYP2C19HIF1A | |
| SCHEMBL12282314 | 0.80 | OPRM1 (0.51) | CES1CES2TSHRCYP2C19HIF1A | |
| SCHEMBL10293315 | 0.80 | OPRM1 (0.51) | CES1CES2TSHRCYP2C19HIF1A | |
| SCHEMBL855690 | 0.79 | CES1 (0.63) | CES1CES2AKR1B1TSHRALDH1A1 | |
| Phenylpyruvate SCHEMBL28005023 | 0.79 | CES1 (0.52) | CES1CES2AKR1B1CYP2C19HIF1A | |
| SCHEMBL28393908 | 0.78 | CES1 (0.61) | CES1CES2AKR1B1TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240368001-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-11-07 | — | — | US | disclosed |
| US-11987506-B2 | Salt recovery solution and processes of use thereof | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2024-05-21 | — | — | US | disclosed |
| US-20230257284-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2023-08-17 | — | — | US | disclosed |
| CN-111225875-B | Salt recovery solution and method of using salt recovery solution | 阿克福特斯技术有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20230043356-A1 | A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2023-02-09 | — | — | US | disclosed |
| EP-3946712-A1 | A SOLVENT DRYING COMPOSITION AND PROCESSES THERFOR | Aquafortus Technologies Limited (NZ) | 2022-02-09 | — | — | EP | disclosed |
| CN-113891760-A | Solvent drying compositions and related methods | 阿克福特斯技术有限公司 | 2022-01-04 | — | — | CN | disclosed |
| US-20200308023-A1 | SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | AQUAFORTUS TECHNOLOGIES LIMITED (NZ) | 2020-10-01 | — | — | US | disclosed |
| EP-3691996-A2 | A SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF | Aquafortus Technologies Limited (NZ) | 2020-08-12 | — | — | EP | disclosed |
| CN-111225875-A | Salt recovery solution and method of using salt recovery solution | 阿克福特斯技术有限公司 | 2020-06-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230043356-A1 | A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR | AQP1, AQP4, NOTUM | CES1 2468/4885CES2 3096/4885AKR1B1 1888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.